Zepbound Tracker App
Track Tirzepatide for Weight Loss
Track your Zepbound (tirzepatide) weekly injections - FDA-approved specifically for weight loss. The dual GIP/GLP-1 agonist delivers up to 22% weight loss. Log doses from 2.5mg to 15mg and monitor your transformation.
What is Zepbound?
Zepbound is the brand name for tirzepatide approved by the FDA specifically for chronic weight management in adults with obesity or overweight with weight-related conditions. It's the same medication as Mounjaro but marketed for weight loss rather than diabetes.
In clinical trials (SURMOUNT), Zepbound showed remarkable results with participants losing up to 22.5% of their body weight - the most significant weight loss ever achieved with any medication. The drug works by activating both GIP and GLP-1 receptors, reducing appetite, increasing feelings of fullness, and slowing gastric emptying.
Zepbound Tracking Features
Weight Charts
Visualize your weight loss journey with beautiful progress charts
Goal Tracking
Set weight goals and track your progress toward them
FAQ
What's the difference between Zepbound and Mounjaro?
They're the same medication (tirzepatide). Mounjaro is approved for type 2 diabetes while Zepbound is approved specifically for obesity/weight loss. Shotlee tracks both.
How much weight can I lose on Zepbound?
Clinical trials showed average weight loss of 22.5% of body weight on the highest dose. Many Shotlee users report losing 50-100+ pounds.
What are the Zepbound dose levels?
Zepbound comes in 6 doses: 2.5mg (starting), 5mg, 7.5mg, 10mg, 12.5mg, and 15mg (maximum). Doses increase every 4 weeks.